BGLC partners with ML Tech to optimize Ethereum treasury strategy

BioNexus Gene Lab Corp

Partnership with ML Tech, an NFA-regulated AI wealth management platform, to optimize BGLC's Ethereum holdings.
ML Tech will provide institutional-grade trading strategies with advanced quantitative models and non-custodial execution.
Partnership follows BGLC's Ethereum treasury strategy to grow reserves while maintaining liquidity, transparency, and control.
CEOs of both companies expressed commitment to digital asset innovation and enhancing shareholder value.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.